Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 542

1.

Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.

Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF Jr, Park HK, Gross EG, Graham GF, Stratton MS, Marshall JR, Clark LC; Nutritional Prevention of Cancer Study Group.

J Natl Cancer Inst. 2003 Oct 1;95(19):1477-81.

PMID:
14519754
2.

Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.

Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR, Clark LC.

Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):630-9.

3.

A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.

Frieling UM, Schaumberg DA, Kupper TS, Muntwyler J, Hennekens CH.

Arch Dermatol. 2000 Feb;136(2):179-84.

PMID:
10677093
4.

Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.

Moon TE, Levine N, Cartmel B, Bangert JL, Rodney S, Dong Q, Peng YM, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):949-56.

5.

Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.

Clark LC, Dalkin B, Krongrad A, Combs GF Jr, Turnbull BW, Slate EH, Witherington R, Herlong JH, Janosko E, Carpenter D, Borosso C, Falk S, Rounder J.

Br J Urol. 1998 May;81(5):730-4.

PMID:
9634050
6.

Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial.

Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1285-91.

7.

Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.

Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL.

Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):157-61.

8.

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR.

JAMA. 1996 Dec 25;276(24):1957-63. Erratum in: JAMA 1997 May 21;277(19):1520.

PMID:
8971064
9.

Reduction of cancer risk with an oral supplement of selenium.

Combs GF Jr, Clark LC, Turnbull BW.

Biomed Environ Sci. 1997 Sep;10(2-3):227-34.

PMID:
9315315
10.

Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.

Levine N, Moon TE, Cartmel B, Bangert JL, Rodney S, Dong Q, Peng YM, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):957-61.

12.

Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.

Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR, Clark LC; Nutritional Prevention of Cancer Study Group.

BJU Int. 2003 May;91(7):608-12.

13.

Nutrition and nonmelanoma skin cancers.

Payette MJ, Whalen J, Grant-Kels JM.

Clin Dermatol. 2010 Nov-Dec;28(6):650-62. doi: 10.1016/j.clindermatol.2010.03.033.

PMID:
21034989
14.

Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial.

Stranges S, Marshall JR, Trevisan M, Natarajan R, Donahue RP, Combs GF, Farinaro E, Clark LC, Reid ME.

Am J Epidemiol. 2006 Apr 15;163(8):694-9. Epub 2006 Feb 22.

PMID:
16495471
15.

Reduction of cancer mortality and incidence by selenium supplementation.

Combs GF Jr, Clark LC, Turnbull BW.

Med Klin (Munich). 1997 Sep 15;92 Suppl 3:42-5.

PMID:
9342915
16.

The nutritional prevention of cancer: 400 mcg per day selenium treatment.

Reid ME, Duffield-Lillico AJ, Slate E, Natarajan N, Turnbull B, Jacobs E, Combs GF Jr, Alberts DS, Clark LC, Marshall JR.

Nutr Cancer. 2008;60(2):155-63. doi: 10.1080/01635580701684856.

PMID:
18444146
17.

Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.

Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA; VATTC Trial.

J Natl Cancer Inst. 2008 Sep 3;100(17):1223-32. doi: 10.1093/jnci/djn262. Epub 2008 Aug 26.

PMID:
18728281
18.

Serum antioxidants and skin cancer risk: an 8-year community-based follow-up study.

van der Pols JC, Heinen MM, Hughes MC, Ibiebele TI, Marks GC, Green AC.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1167-73. doi: 10.1158/1055-9965.EPI-08-1211. Epub 2009 Mar 31.

19.

Nonmelanoma skin cancer in the United States: incidence.

Miller DL, Weinstock MA.

J Am Acad Dermatol. 1994 May;30(5 Pt 1):774-8.

PMID:
8176018
20.

A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group.

Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, Elias PM, Lowe N, Nierenberg DW, Bayrd G, et al.

N Engl J Med. 1990 Sep 20;323(12):789-95. Erratum in: N Engl J Med 1991 Oct 31;325(18):1324.

Supplemental Content

Support Center